product

Xeris Biopharma Holdings Inc

manipulation

$XERS  This stock has become totally distorted by Wall Street manipulators!

In fact its just market manipulation by  shorts and rich assholes who use stocks like slot machines.

$XERS This stock is heavily MANIPULATED by a &quot;Gang of Shortsellers&quot; and has nothing to do with a fair market price!

It is so obvious this is being systematically walked down (manipulated) and has nothing to do with the Company itself, products, or the overall market.

Just goes to show how badly manipulated this is.

The manipulation of these criminals is unbelievable.

price

This Share Price is still 
 
Crazy  
 
Stupid  
 
Low. Cheers!

$XERS  This share price is crazy stupid low.

You’d think Paul would have some shame being below their price.

What is most disappointing about XERS, except for the collapse in stock price, is the failure of management to do much of anything to encourage retail or institutional investors to continue to have the confidence in management of the company or its future.

I think price targets are fake… there compensated to make targets IMO.

suck

Unfortunately, the mkt sucks now and that’s reflected in sp.

The whole market sucks and this has been unjustly hammered.

$XERS this is so fucked up its unbelievable.

Invested a lot of money , and realizing we are fucked.

market

What a crappy market! Hopefully next week will be better:)

$XERS A bad market must admit it is really a bad day.

$XERS A 10+ cent drop when you only have 14 of those until 0 ahead of all that gobbledygook fundamental longs are spouting is not a great sign of market confidence.

$XERS market on a year and this lame duck is flat or sinking

but unfortunately, in this market, not cheap either, and even less an outright buy without a very very strong conviction.

Market hinting something is terribly wrong with this company.

revenue

$XERS High risk is an understatement with XERS, weak drug lineup, weak pipeline, revenue grow slowing, cash burn increasing and worse than weak management should tell you to stay away.

Nothing positive, revenue continues to slow, spending increasing, generics coming, recorlev under performing and most important, incompetent management! !

Personally, I think this is very conservative, and comes in below the Strongbridge &quot;Low Case&quot; from page 87 of the merger prospectus because it comes out to $172M annual revenue in 2023 compared to $216M revenue on the prospectus.

Revenues are slowing, expenses are increasing, tech is marginal, patents will be expiring, pipeline is horrible and management is horrible.

but also very disappointing that my EV charger stocks have $Billion mkt caps with less than $50M revenue and years from cash flow positive and yet.

Not only are the current drugs low revenue producers and the pipeline is horrible.

.WS not impressed with 3 low revenue drugs and weak pipeline.

$XERS their primary product increases 9% week to week sales with an overall trend that&#39;s incredible.

$XERS I like their products and the inject opportunity with Horizon Tepezza is huge I wish they weren&#39;t acquired so they can keep a focus on that.

Earnings are growing and there could be great news any day from a variety of sources, whether a collab exercise of option, new product collab, royalty pmt, etc.

More important is that they grow Recorlev&#39;s revenue at high(er) speed, and continue to gain market share with Gvoke without product price drop.

Revenue exploding on the upside with
their 4 products.

Even if they have more short term gains coming soon, we know the Gvoke product will gain share back due to the more pleasant experience. Patience.

Gvoke is the best and easiest product out there.

Products have been approved and much more is coming, wait and relax.

For a tiny company like xeris to go toe to toe with lilly and grow share shows they have the best product.

$XERS Truly so strange, everything Xeris had in its programme has been met, briefly 3 FDA approved products, collaborations with major pharmacies and much, much more.

Two other drugs, each growing revenue steadily.

That said, I fully expect continuing  script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.

Two (2) other drugs, each growing revenue steadily.

There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.

drug

A levothyroxine formulation that looks positive (most commonly prescribed drug) A full proven technology platform to deliver hard to administer drugs by a simple injection.

We have other amazing drugs, Recorlev, Gvoke and more including some drugs yet to be approved.

$XERS Good market yesterday, looking good today and good old XERS continues in the tank!!

but all of last week, in the middle of heavy market turmoil where we normally go down heavily, we stayed up and rose. Why?

Plenty of small caps were brought to lows (and thus made good buys) before starting recovery in this bear market, $ADMA, $ARAY, $PRTK, $CDTX, they all have turned or are turning around cause there is deep value and a clear path to profitability.

patient

$XERS On Gvoke, &quot;better than expected growth&quot;:   
&quot;Opportunity remains huge, and you don&#39;t have to find patients.

QoQ growth would still increase by ~40% with no new patients.

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Baudax Bio Inc

crash

$BXRX This is like a bloody car crash - I cannot look away.

flow

Money flow now &quot;extreme bearish.&quot;

management

BXRX management and BOD are the definition of FAILURE!!

$BXRX Watching all the new bulls here compared to a month ago, some of you will end up bag holding this for a long time.. this company has some of the most selfish management in the entire market.

This can only be due to fraudulent practices on the part of Baudax Bio management, such as misrepresenting the market potential of Anjeso, lying about the CEO&#39;s credentials, colluding with short sellers, etc.

i’ve watched it for years.. nothing good ever happens with management

Stay far, far away from this toxic stock, company and management.

but that this  company is allowed to continue to serve as an ATM for management, while fleecing investors, is an absolute travesty.

BXRX management should be in jail for what they did to this company.

Company has no viable products, no revenue, incompetent, self-dealing management, multiple dilutions and reverse splits.

split

Look at all the reverse splits in this turd.

$BXRX fucking turds, two splits in one year, Good lord.

$BXRX  😂😂 and yet another split on the way,  what a horrific stock.

A 1 for 40 reverse stock split and an immediate dilution/stock offering……..in other words………a savage ass pounding without even a cigarette break.

stop

but this thang don’t stop tumbling down the mountain

$BXRX Even if they don&#39;t sell Anjeso, the product is unique in a market with great potential.

$EMED QB ticker announced  new product , .01-.03 nice % incoming i believe

$BXRX THE COMPANY HAS AN EXCELLENT PRODUCT MILOXICAM IV FOR PAIN RELIEF.

A unique product on the market that will soon be marketed internationally as well.

news

$ENSC big news coming in days ahead,  very cheap.

Mid day top percent stock gainers on news and/or vol.

$INPX $BIAF $GROM $BXRX $COSM  very strong holding  above 1.90 that great news for tomorrow

We are the only low float good news stock today.

Analysts have set a price target of $3 for ENSC&#39;s stock, making it a strong buy for those looking to invest in the future of the industry🔥🚀 
 
Also following: 
$THMO $HUBC $TRKA $BXRX

$REVB More and More buys from all over the market are entering here now.

$INPX volume swelling on buys coming in locking it up
$BXRX go bulls!

🚨   $SPRC This could be the greatest buy in small caps right now or at least one of them.

Prty more up, cosm $4 buy spot,  Htgm filling premarket, slapping in 🔥

hold

$BXRX Long term hold for me PT 10 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

.It will move on thin air 
$sidu is a nice hold 
$boxd nice volume.

$BXRX Once again bulls prove they can&#39;t hold shit

$BXRX as long as it holds the VWAP it is still bullish.

alert

Alerts performance update1 
 
$HUBC alert is 🆙 67% 
$ENZ  🆙24% 
$BXRX  🆙 24% 
$CRBP 🆙 128% 
$AIMD  🆙 41%

Notice that with 1620 winning alerts, we average a 24% gain per winning alert that was issued this year.

$DBGI .49 to $5.25 50.4% 🎯
$KTRA  $5.99 to $14 128% 🎯
$HTGM  .25 to .95 279% 🎯
$BXRX 4&#39;s to $7.10 56% 🎯

Now $VLON 🎯 🤑🏦🚀

I’ll keep the free alerts coming for Christmas - follow more ideas!

$BXRX Estimated S.I as on   10/12/22 20.06 Percent          
               
 Our members get trade alerts on my calls &amp;puts, we are up 100% in our portfolio trading the puts and calls even in the bear market.

SCWorx Corp

pump-and-dump

$WORX This is an example of a shitco stock that is subject to a Pump &amp; Dump scheme every 3-6 months (which never lasts).

$WORX Shorts will lose the battle and the war.

wall

short

$WORX Shorts are bagged spreading erroneous and unfounded nonsense.

The new product offering enables hospitals of all sizes to quickly and easily benefit from the SCWorx data platform.

New products and a chart with mega upside. 🚀

$WORX Business booming with more clients new products and a chart bottomed ready to go 🚨🚨🚨❗️💎 a gem

$WORX is consistent with good PR, new contracts, new products and stock purchase deals with institutional investors!

play

$IVDA  $WORX has potential for play of the month even year with a set up like this.

Now i am calling $WORX - huge 13g and bottomed chart, this will be the next big undervalue play.

$WORX The unequivocal top technology play for hospitals and medical purposes.

$WORX HOD break out in play 👀🚨🚨🚨🔜

$WORX 💎This is my favorite play right now by far, i am swinging for big gains.💎 
 
$CMPO 18% short!

float

insider

The price action is of a winner 🚨🚨🚨🚀👀
$WORX Insiders been loading.

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Mar, 17, 2023

Mar, 14, 2023

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Nov, 29, 2022

Nov, 5, 2022

WORX

SCWorx Corp

-25.75%

$0.44 - $0.33

Dec, 5, 2022

Dec, 5, 2022

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Mar, 17, 2023

Mar, 14, 2023

Jan, 23, 2023

Jan, 5, 2023

Jan, 1, 2023

Dec, 23, 2022

Dec, 23, 2022

Dec, 13, 2022

Nov, 4, 2022

Nov, 2, 2022

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Nov, 29, 2022

Nov, 5, 2022

Oct, 11, 2022

Oct, 7, 2022

WORX

SCWorx Corp

-25.75%

$0.44 - $0.33

Dec, 5, 2022

Dec, 5, 2022

Dec, 5, 2022

Dec, 5, 2022